XML 39 R29.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Derivative Instruments and Hedging Activities (Tables)
9 Months Ended
Mar. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Fair value of derivatives
(in thousands)March 31, 2024
June 30, 2023
Derivatives designated as hedging instruments
Other current assets - range forward contracts$126 $— 
Total derivatives designated as hedging instruments126 — 
Derivatives not designated as hedging instruments
Other current assets - currency forward contracts$$68 
Other current liabilities - currency forward contracts(10)(100)
Total derivatives not designated as hedging instruments(7)(32)
Total derivatives$119 $(32)
(Gains) losses related to derivatives not designated as hedging instruments related to derivatives not designated as hedging instruments have been recognized as follows:
Three Months Ended March 31,Nine Months Ended March 31,
(in thousands)2024202320242023
Other (income) expense, net - currency forward contracts$14 $56 $43 $(447)
Schedule of Net Investment Hedges, Statements of Financial Performance and Financial Position, Location
As of March 31, 2024, the foreign currency-denominated intercompany loans payable designated as net investment hedges consisted of:
Instrument
Notional
(EUR and CNY in thousands)(2)
Notional
(USD in thousands)(2)
Maturity
Foreign currency-denominated intercompany loan payable10,147 $10,967 June 2024
Foreign currency-denominated intercompany loan payable11,007 $11,897 June 2024
Foreign currency-denominated intercompany loan payable¥110,710 $15,316 November 2024
Foreign currency-denominated intercompany loan payable¥109,136 $15,098 February 2025
(2) Includes principal and accrued interest.
Schedule of Cash Hedges
The following represents gains (losses), net of tax, related to cash flow hedges:
Three Months Ended March 31,Nine Months Ended March 31,
(in thousands)2024202320242023
Unrealized gain (loss) recognized in other comprehensive income$16 $— $(43)$— 
No portion of the gains or losses recognized in earnings was due to ineffectiveness and no amounts were excluded from our effectiveness testing for the three months ended March 31, 2024 and 2023.